<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.6.40">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>thesis – blog</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting-549806ee2085284f45b00abea8c6df48.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap-a8844f51f2da6c20986fda27dad00578.min.css" rel="stylesheet" append-hash="true" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "navbar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "end",
  "type": "overlay",
  "limit": 50,
  "keyboard-shortcut": [
    "f",
    "/",
    "s"
  ],
  "show-item-context": false,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-text-placeholder": "",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit",
    "search-label": "Search"
  }
}</script>


<link rel="stylesheet" href="styles.css">
</head>

<body class="nav-fixed fullcontent">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
    <nav class="navbar navbar-expand-lg " data-bs-theme="dark">
      <div class="navbar-container container-fluid">
      <div class="navbar-brand-container mx-auto">
    <a class="navbar-brand" href="./index.html">
    <span class="navbar-title">blog</span>
    </a>
  </div>
            <div id="quarto-search" class="" title="Search"></div>
          <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarCollapse" aria-controls="navbarCollapse" role="menu" aria-expanded="false" aria-label="Toggle navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
  <span class="navbar-toggler-icon"></span>
</button>
          <div class="collapse navbar-collapse" id="navbarCollapse">
            <ul class="navbar-nav navbar-nav-scroll ms-auto">
  <li class="nav-item">
    <a class="nav-link" href="./about.html"> 
<span class="menu-text">About</span></a>
  </li>  
  <li class="nav-item compact">
    <a class="nav-link" href="https://github.com/"> <i class="bi bi-github" role="img">
</i> 
<span class="menu-text"></span></a>
  </li>  
  <li class="nav-item compact">
    <a class="nav-link" href="https://www.linkedin.com/in/nicholas-monogioudis/"> <i class="bi bi-linkedin" role="img">
</i> 
<span class="menu-text"></span></a>
  </li>  
</ul>
          </div> <!-- /navcollapse -->
            <div class="quarto-navbar-tools">
</div>
      </div> <!-- /container-fluid -->
    </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article page-navbar">
<!-- sidebar -->
<!-- margin-sidebar -->
    
<!-- main -->
<main class="content" id="quarto-document-content"><header id="title-block-header" class="quarto-title-block"></header>




<p>The Role of Inflammation in Alzheimer’s Development</p>
<p>INTRODUCTION</p>
<p>Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that leads to memory loss, confusion, and a gradual decline in both cognitive and physical abilities (Alzheimer's Association, 2023). As global life expectancy continues to rise, the prevalence of AD is also increasing, which places a lot pressure on patients, their families, and healthcare systems around the world (Prince et al., 2015). Today, AD ranks among the leading causes of dementia and disability in older adults, which causes serious challenges not only to patients but also to caregivers and society as a whole (World Health Organization, 2022).</p>
<p>For decades, the predominant explanation for Alzheimer’s has been the “amyloid hypothesis,” which credits the disease to the accumulation of amyloid-beta plaques and tau tangles in the brain (Hardy &amp; Selkoe, 2002). These abnormal protein build-ups disrupt neuronal communication, trigger cell death, and have been central to most research and therapeutic strategies (Selkoe &amp; Hardy, 2016). Genetic factors, such as the APOE4 gene, have also been linked to increased risk and progression of AD (Liu et al., 2013). While the amyloid hypothesis has guided much of the scientific investigation, treatments targeting amyloid plaques have mostly fallen short in giving significant clinical benefits (Cummings et al., 2019). This has led researchers to explore alternative mechanisms that may contribute to the onset and progression of Alzheimer’s.</p>
<p>Emerging evidence points to chronic inflammation as a critical driver of AD pathology. Unlike acute inflammation, which is a short-term and protective immune response, chronic inflammation is a prolonged state that disrupts normal physiological functions (Heppner et al., 2015). In the brain, this persistent inflammation can arise from factors such as metabolic dysfunction, oxidative stress, and unhealthy lifestyle habits (Heneka et al., 2015). Over time, these triggers activate immune cells like microglia and astrocytes, which, instead of protecting neurons, begin to release inflammatory molecules that damage healthy brain cells (Glass et al., 2010). This inflammatory environment not only accelerates the formation of amyloid plaques and tau tangles but also impairs synaptic communication and neuronal survival (Wyss-Coray &amp; Rogers, 2012).</p>
<p>This paper argues that chronic inflammation is not merely a byproduct of Alzheimer’s disease but a fundamental contributor to its development and progression. Specifically, this paper proposes that metabolic and immune dysregulation underlie the chronic inflammatory state observed in AD. Understanding how inflammation interacts with other pathological processes, such as amyloid and tau aggregation, may provide crucial insights into the disease’s mechanisms. By targeting the root causes of neuroinflammation—whether through lifestyle interventions, anti-inflammatory treatments, or metabolic regulation—we may open new avenues for slowing or even preventing the progression of Alzheimer’s disease (Heneka et al., 2018).</p>
<p>This hypothesis is supported by recent studies that link inflammation markers to cognitive decline (Walker et al., 2019) and displays the presence of pro-inflammatory cytokines in the brains of Alzheimer’s patients (Suarez-Calvet et al., 2016). Additionally, experimental models have shown that reducing inflammation can better neuronal damage and improve cognitive function (Yin et al., 2021). These findings highlight the need to shift our focus beyond amyloid-centric approaches and towards addressing the multifaceted role of inflammation in AD. By doing so, we can move closer to developing more effective therapeutic strategies for this devastating disease.</p>
<p>THE ROLE OF NEUROINFLAMMATION IN ALZHEIMER’S PATHOLOGY</p>
<p>Neuroinflammation is now recognized as a major contributor to Alzheimer’s disease. A key part of this is the role of microglia which are immune cells in the brain that keep things balanced by responding to injuries, infections, and other disruptions. In Alzheimer’s disease, microglia (the brain’s resident immune cells) are constantly activated. This is different from their normal transient activation during acute immune responses (Heneka et al., 2015). This chronic activation causes a cascade of damaging effects, including the release of pro-inflammatory cytokines like IL-1β and TNF-α, as well as reactive oxygen species, which lead to synaptic dysfunction and neuronal death (Glass et al., 2010; Suarez-Calvet et al., 2016). As microglia continuously attack neurons, they contribute to the disruption of synaptic connections and increase cognitive decline and memory impairments characteristic of Alzheimer’s disease (Wyss-Coray &amp; Rogers, 2012). This suggests that microglial dysregulation is a central mechanism driving neurodegeneration in AD, perpetuating the cycle of inflammation and neuronal loss. This highlights how immune dysregulation contributes not just to neuronal loss but also to the overall progression of AD.</p>
<p>As stated above, cytokines have a prominent role in Alzheimer's disease. Key molecules like interleukin-1β (IL-1β), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) all have higher levels in the brains of people with AD. As a result, synaptic function and plasticity are affected. The increase in cytokine levels not only helps trigger the hyperphosphorylation of tau (a major hallmark of AD) which weakens neurons even more (Wyss-Coray &amp; Rogers, 2012), they also make it easier for amyloid plaques to form. This creates a cycle of inflammation and neuronal damage.</p>
<p>In addition to the direct effects of cytokines, a key part of AD is the back-and-forth between amyloid-beta build-up and brain inflammation. When amyloid-beta plaques pile up in the brains of people with Alzheimer’s, they signal to fire inflammatory molecules from microglia, which then speed up the deposits of even more amyloid-beta. This cycle of plaques causing inflammation, and inflammation causing more plaques, really drives the progression of the disease. Studies suggest that breaking this loop could help lower plaque build-up and slow down the disease, making neuroinflammation an exciting target for new treatments (Heppner et al., 2015). Since the link between amyloid-beta and inflammation is very complicated, targeting the inflammation might help stop this. Ths gives hope for future therapies that could delay or even prevent Alzheimer’s. Thus, getting a better handle on inflammation is essential for finding more effective treatments.</p>
<p>GENETIC RISK FACTORS AND INFLAMMATORY PATHWAYS</p>
<p>Genetic factors play a crucial role in determining the risk of developing Alzheimer’s disease (AD), with differences in certain genes significantly influencing the brain's inflammatory responses. Among these, changes in the TREM2 gene and the APOE4 allele are particularly noteworthy for their contributions to the onset and progression of Alzheimer's disease. These genetic factors are linked not only to an increased susceptibility to AD but also to the modulation of neuroinflammation, a hallmark of the disease.</p>
<p>One of the most studied genes in relation to Alzheimer's risk is TREM2 (Triggering Receptor Expressed on Myeloid Cells 2). TREM2 is involved in the functioning of microglia. Variations in the TREM2 gene, particularly rare mutations, have been shown to impair the ability of microglia to respond effectively to neurodegenerative signals. As a result, this increases neuroinflammation and accelerates the progression of AD. Guerreiro et al.&nbsp;(2013) demonstrated that mutations in the TREM2 gene lead to a big reduction in the ability of microglia to efficiently manage amyloid-beta plaques and other neurotoxic agents. This impairment not only results in the accumulation of amyloid plaques but also contributes to a chronic inflammatory environment that exacerbates neuronal damage. The disruption of microglial clearance and the subsequent rise in inflammatory cytokines fuels the neurodegenerative process, creating a cycle that accelerates cognitive decline.</p>
<p>In addition to TREM2 mutations, the APOE4 allele is another major genetic risk factor for Alzheimer's disease. APOE4, a variant of the apolipoprotein E gene, has been well established as a genetic variant that increases the risk of Alzheimer’s and is particularly associated with an earlier onset of the disease. The presence of the APOE4 allele has been shown to enhance inflammation in the brain by promoting the production of pro-inflammatory molecules, including cytokines and chemokines. According to Mahley and Huang (2012), APOE4 not only increases the production of these inflammatory molecules but also impairs the ability of microglia to clear amyloid-beta plaques, leading to a further accumulation of plaques and greater neuronal damage. In particular, APOE4 has been shown to alter the response of microglia, making them less effective at resolving inflammation and promoting tissue repair, thus worsening the neurodegenerative process (Li et al., 2015).</p>
<p>Together, these genetic factors highlight the central role of immune dysfunction in the pathogenesis of Alzheimer's disease. Both TREM2 mutations and the APOE4 allele emphasize how genetic variations can influence the brain’s inflammatory pathways and contribute to the disease. The findings suggest that addressing neuroinflammation, potentially through the influence of microglial activity or the inhibition of pro-inflammatory signaling pathways, could be a promising therapeutic strategy for Alzheimer’s disease. These insights have opened new avenues for research aimed at understanding the intricate relationship between genetics, inflammation, and neurodegeneration in Alzheimer's. Further studies on the interaction between genetic risk factors and inflammatory processes are essential for developing targeted interventions that may help mitigate the devastating effects of Alzheimer’s disease.</p>
<p>PERIPHERAL INFLAMMATION AND ITS CONTRIBUTION TO ALZHEIMER’S</p>
<p>Peripheral inflammation plays a large complex role in kickstarting and speeding the progression of Alzheimer’s disease. It’s driven by several factors that ramp up body-wide inflammation and set off inflammatory responses in the brain. One major player in this process is the gut-brain axis, which Cryan and colleagues (2019) explored. They showed that gut bacteria have a real impact on brain inflammation. Emerging evidence suggests that gut microbiota imbalances, or dysbiosis, contribute to systemic inflammation, which can exacerbate neuroinflammation in Alzheimer’s disease. Dysbiosis has been shown to elevate inflammatory markers such as C-reactive protein (CRP) and pro-inflammatory cytokines in the bloodstream (Cryan et al., 2020). These markers may cross the blood-brain barrier, triggering inflammatory responses in the central nervous system (Fung et al., 2017). In the context of AD, such inflammation promotes the aggregation of amyloid-beta plaques and tau tangles, accelerating disease progression (Cattaneo et al., 2017; Harach et al., 2017). These findings underscore the potential role of the gut-brain axis in modulating neuroinflammation and highlight the need for therapeutic strategies targeting gut health to mitigate AD progression. Cryan et al.&nbsp;also point out a connection between metabolic problems, like obesity, insulin resistance, and brain inflammation. They propose that inflammation triggered by these metabolic problems might contribute to AD. Of these, insulin resistance plays a big role in Alzheimer’s development since it can harm brain function and encourage the buildup of amyloid plaques.</p>
<p>Craft (2005) highlights how systemic diseases, especially heart problems and diabetes, contribute to brain inflammation and cognitive decline. Conditions like high blood pressure, high cholesterol, and type 2 diabetes raise the chances of developing Alzheimer's by increasing peripheral inflammation throughout the body. These diseases boost the levels of pro-inflammatory cytokines, which can make their way to the brain and activate glial cells. This kind of chronic inflammation is a major risk factor for cognitive decline and brain cell damage, and having these conditions over time speeds up the development of Alzheimer's.</p>
<p>Besides metabolic and cardiovascular factors, chronic stress also plays a big role in inflammation and its link to Alzheimer's disease. According to McEwen (2012), stress hormones, especially cortisol, can harm the brain by triggering the production of inflammatory molecules. Long-term exposure to high cortisol levels has been linked to a higher risk of cognitive decline and dementia, as it also activates microglia. On top of that, stress-related inflammation can make other Alzheimer’s risk factors, like high blood pressure worse, creating a cycle that speeds up cognitive decline. McEwen’s research shows how our social environment, particularly chronic stress, can play a key role in the development of AD.</p>
<p>CONTRASTING PERSPECTIVES: IS INFLAMMATION A CAUSE OR EFFECT?</p>
<p>The understanding of inflammation's role in Alzheimer’s disease (AD) has evolved significantly, with two primary perspectives emerging. Historically, the amyloid cascade hypothesis, introduced by Hardy and Higgins (1992), has dominated the field. This hypothesis posits that amyloid-beta plaques are the central cause of AD, with inflammation acting as a secondary response to plaque accumulation. According to this view, the presence of plaques causes a series of detrimental processes, including the activation of microglia and other immune cells (Heneka et al., 2015; Glass et al., 2010). In this framework, inflammation is regarded as an unavoidable consequence of amyloid accumulation, amplifying the damage and presenting a secondary target for therapeutic intervention (Wyss-Coray &amp; Rogers, 2012).</p>
<p>However, this traditional view has been challenged. Herrup (2015) argues against the primacy of amyloid-beta as the primary driver of AD and questions whether inflammation is merely a downstream effect. He proposes that AD may instead originate from natural cellular dysfunction, such as damaged repair mechanisms or the failure of vital cellular processes. For example, defects in DNA repair or mitochondrial function can compromise neuronal health, leading to cellular stress and subsequent inflammation (Cai et al., 2012; Swerdlow, 2018). According to Herrup, these fundamental cellular problems may precede or occur independently of amyloid-beta accumulation and inflammation. From this outlook, amyloid-beta buildup is seen as a consequence rather than a cause of cellular dysfunction, and inflammation may arise as a reaction to cellular stress rather than playing a causative role in disease progression.</p>
<p>This shift in focus away from amyloid-beta as the primary culprit suggests that treatments exclusively targeting amyloid plaques may not address the underlying causes of AD. For instance, clinical trials of amyloid-targeting therapies have shown limited success in improving cognition, further supporting the need to explore alternative mechanisms (Cummings et al., 2019). Herrups hypothesis calls for a broader investigation into the cellular dysfunctions that precede or occur alongside amyloid-beta accumulation and inflammation. Such an approach highlights the need to explore any relationships between these factors. Demonstrating that inflammation is not merely an effect, but a contributing cause of AD remains a significant challenge in the current state of research. Nonetheless, longitudinal studies and experimental models are beginning to provide evidence that chronic inflammation can directly influence amyloid-beta production and tau pathology, offering new insights into disease progression (Heppner et al., 2015; Heneka et al., 2018).</p>
<p>These differing perspectives underscore the complexity of Alzheimer’s disease. They emphasize the importance of continued research to unravel how inflammation, amyloid-beta, and cellular dysfunction interact in the progression of the disease. Understanding these relationships will be critical in developing comprehensive approaches to prevent and treat AD effectively. By focusing on the interplay between inflammation and cellular health, researchers may uncover novel therapeutic strategies that address the root causes of Alzheimer’s disease, potentially slowing or halting its progression.</p>
<p>CONCLUSION</p>
<p>In conclusion, neuroinflammation is increasingly recognized as a critical factor in Alzheimer’s disease (AD), prompting a shift in focus from the traditional viewpoint on amyloid plaques and tau tangles. Studies have demonstrated that inflammation in the brain is not merely a consequence of AD but a driving force that increases neuronal and synaptic damage. This ultimately contributes to cognitive decline and memory loss (Heneka et al., 2015; Heppner et al., 2015). Activation of glial cells, particularly microglia and astrocytes, leads to the release of pro-inflammatory cytokines such as interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), while also disrupting the blood-brain barrier. Altogether, hese processes accelerate the progression of AD by amplifying neurodegeneration and facilitating the accumulation of amyloid-beta and tau pathology (Wyss-Coray &amp; Rogers, 2012; Sweeney et al., 2019).</p>
<p>Given this evidence, neuroinflammation has emerged as a promising target for therapeutic interventions. Recent research has identified specific inflammatory pathways, such as the NLRP3 inflammasome and complement system, as potential areas for therapeutic focus (Heneka et al., 2018; Hong et al., 2016). Moving forward, it is important to dive deeper into the complex interactions between inflammation and other pathological processes in AD, including oxidative stress, mitochondrial dysfunction, and vascular abnormalities (Swerdlow, 2018; Cai et al., 2012). This integrative understanding could pave the way for novel treatments that address the root causes of AD by modulating inflammatory responses.</p>
<p>By recognizing inflammation as a key player rather than a secondary effect, researchers and clinicians can develop more comprehensive strategies for diagnosing, preventing, and treating AD. These strategies may include anti-inflammatory therapies, lifestyle changes, and interventions targeting the gut-brain axis to reduce systemic inflammation (Cummings et al., 2019; Cryan et al., 2020). These advances have the potential to transform the way we look at Alzheimer’s disease, offering hope for improved outcomes, quality of life, and perhaps even prevention in the future. Ultimately, this shift highlights the importance of addressing inflammation as part of an alternative approach to combating AD.</p>
<p><strong>Works Cited</strong></p>
<ul>
<li><p>Alzheimer’s Disease Facts and Figures. (n.d.). In <em>Alzheimer’s Disease and Dementia</em>. Alzheimer’s Disease and Dementia. Retrieved December 14, 2024, from <a href="https://www.alz.org/alzheimers-dementia/facts-figures" class="uri">https://www.alz.org/alzheimers-dementia/facts-figures</a></p></li>
<li><p>Cattaneo, A., Cattane, N., &amp; Galluzzi, S. (n.d.). Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. <em>National Library of Medicine</em>. Retrieved December 14, 2024, from <a href="https://pubmed.ncbi.nlm.nih.gov/27776263" class="uri">https://pubmed.ncbi.nlm.nih.gov/27776263</a></p></li>
<li><p>Craft, S. (2005). Insulin resistance syndrome and Alzheimer’s disease: age- and obesity-related effects on memory, amyloid, and inflammation. In <em>Neurobiology of aging: Vol. 26 Suppl 1</em> (pp. 65–69). <em>Neurobiology of aging</em>. <a href="https://doi.org/10.1016/j.neurobiolaging.2005.08.021" class="uri">https://doi.org/10.1016/j.neurobiolaging.2005.08.021</a></p></li>
<li><p>Cummings, J. L., Tong, G., &amp; Ballard, C. (2019). Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options. In <em>Journal of Alzheimer’s disease: JAD</em> (Vol. 67, Issue 3, pp.&nbsp;779–794). <em>Journal of Alzheimer’s disease: JAD</em>. <a href="https://doi.org/10.3233/JAD-180766" class="uri">https://doi.org/10.3233/JAD-180766</a></p></li>
<li><p>Fung, T. C., Olson, C. A., &amp; Hsiao, E. Y. (2017). Interactions between the microbiota, immune and nervous systems in health and disease. <em>National Library of Medicine</em>. <a href="https://pubmed.ncbi.nlm.nih.gov/28092661" class="uri">https://pubmed.ncbi.nlm.nih.gov/28092661</a></p></li>
<li><p>Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., McCoy, K. D., Frisoni, G., Neher, J. J., Fk, F., Jucker, M., Lasser, T., &amp; Bolmont, T. (2017). Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. In <em>Scientific reports</em> (Vol. 7, pp.&nbsp;41802–41802). <em>Scientific reports</em>. <a href="https://doi.org/10.1038/srep41802" class="uri">https://doi.org/10.1038/srep41802</a></p></li>
<li><p>Hardy, J. A., &amp; Higgins, G. A. (1992). Alzheimer’s disease: the amyloid cascade hypothesis. <em>National Library of Medicine</em>. <a href="https://pubmed.ncbi.nlm.nih.gov/1566067" class="uri">https://pubmed.ncbi.nlm.nih.gov/1566067</a></p></li>
<li><p>Heneka, M. T., McManus, R. M., &amp; Latz, E. (2018). Inflammasome signalling in brain function and neurodegenerative disease. In <em>Nature reviews. Neuroscience</em> (Vol. 19, Issue 10, pp.&nbsp;610–621). <em>Nature reviews. Neuroscience</em>. <a href="https://doi.org/10.1038/s41583-018-0055-7" class="uri">https://doi.org/10.1038/s41583-018-0055-7</a></p></li>
<li><p>Herrup, K. (2015). The case for rejecting the amyloid cascade hypothesis. In <em>Nature neuroscience</em> (Vol. 18, Issue 6, pp. 794–799). <em>Nature neuroscience</em>. <a href="https://doi.org/10.1038/nn.4017" class="uri">https://doi.org/10.1038/nn.4017</a></p></li>
<li><p>Hong, S. (2016). Complement and microglia mediate early synapse loss in Alzheimer mouse models. <em>National Library of Medicine</em>. <a href="https://pubmed.ncbi.nlm.nih.gov/27033548" class="uri">https://pubmed.ncbi.nlm.nih.gov/27033548</a></p></li>
<li><p>McEwen, B. S. (1993). Brain on stress: how the social environment gets under the skin. <em>National Library of Medicine</em>. <a href="https://pubmed.ncbi.nlm.nih.gov/23045648" class="uri">https://pubmed.ncbi.nlm.nih.gov/23045648</a></p></li>
<li><p>Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., &amp; Zlokovic, B. V. (2019). Blood-Brain Barrier: From Physiology to Disease and Back. In <em>Physiological reviews</em> (Vol. 99, Issue 1, pp. 21–78). <em>Physiological reviews</em>. <a href="https://doi.org/10.1152/physrev.00050.2017" class="uri">https://doi.org/10.1152/physrev.00050.2017</a></p></li>
<li><p>Swerdlow, R. H. (n.d.). Mitochondria and Mitochondrial Cascades in Alzheimer’s Disease. <em>National Library of Medicine</em>. Retrieved December 14, 2024, from <a href="https://pubmed.ncbi.nlm.nih.gov/29036828" class="uri">https://pubmed.ncbi.nlm.nih.gov/29036828</a></p></li>
<li><p>Zhang, G., Wang, Z., Hu, H., Zhao, M., &amp; Sun, L. (2021). Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention. In <em>Frontiers in cellular neuroscience</em> (Vol. 15, pp.&nbsp;749587–749587). <em>Frontiers in cellular neuroscience</em>. <a href="https://doi.org/10.3389/fncel.2021.749587" class="uri">https://doi.org/10.3389/fncel.2021.749587</a></p></li>
<li><p>Glass, C. K. (2010). Mechanisms underlying inflammation in neurodegeneration. <em>National Library of Medicine</em>. <a href="https://pubmed.ncbi.nlm.nih.gov/20303880" class="uri">https://pubmed.ncbi.nlm.nih.gov/20303880</a></p></li>
<li><p>Hardy, J., &amp; Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. <em>National Library of Medicine</em>. <a href="https://pubmed.ncbi.nlm.nih.gov/12130773" class="uri">https://pubmed.ncbi.nlm.nih.gov/12130773</a></p></li>
<li><p>Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., Herrup, K., Frautschy, S. A., Finsen, B., Brown, G. C., Verkhratsky, A., Yamanaka, K., Koistinaho, J., Latz, E., Halle, A., … Golenbock, D. T. (2015). Neuroinflammation in Alzheimer’s disease. In <em>The Lancet. Neurology</em> (Vol. 14, Issue 4, pp.&nbsp;388–405). <em>The Lancet. Neurology</em>. <a href="https://doi.org/10.1016/S1474-4422(15)70016-5" class="uri">https://doi.org/10.1016/S1474-4422(15)70016-5</a></p></li>
<li><p>Heppner, F. L., Ransohoff, R. M., &amp; Becher, B. (2015). Immune attack: the role of inflammation in Alzheimer disease. In <em>Nature reviews. Neuroscience</em> (Vol. 16, Issue 6, pp.&nbsp;358–372). <em>Nature reviews. Neuroscience</em>. <a href="https://doi.org/10.1038/nrn3880" class="uri">https://doi.org/10.1038/nrn3880</a></p></li>
<li><p>Li, X., Song, D., &amp; Leng, S. X. (2015). Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment. In <em>Clinical interventions in aging</em> (Vol. 10, pp. 549–560). <em>Clinical interventions in aging</em>. <a href="https://doi.org/10.2147/CIA.S74042" class="uri">https://doi.org/10.2147/CIA.S74042</a></p></li>
<li><p>Liu, C.-C. (2013). Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. <em>National Library of Medicine</em>. <a href="https://pubmed.ncbi.nlm.nih.gov/23296339" class="uri">https://pubmed.ncbi.nlm.nih.gov/23296339</a></p></li>
<li><p>Mahley, R. W., &amp; Huang, Y. (2012). Apolipoprotein E sets the stage: response to injury triggers neuropathology. In <em>Neuron</em> (Vol. 76, Issue 5, pp.&nbsp;871–885). <em>Neuron</em>. <a href="https://doi.org/10.1016/j.neuron.2012.11.020" class="uri">https://doi.org/10.1016/j.neuron.2012.11.020</a></p></li>
<li><p>Selkoe, D. J., &amp; Hardy, J. (2016). The amyloid hypothesis of Alzheimer’s disease at 25 years. <em>National Library of Medicine</em>. <a href="https://pubmed.ncbi.nlm.nih.gov/27025652" class="uri">https://pubmed.ncbi.nlm.nih.gov/27025652</a></p></li>
<li><p>Suárez-Calvet, M., Kleinberger, G., Caballero, M. Á., Brendel, M., Rominger, A., Alcolea, D., Fortea, J., Lleó, A., Blesa, R., Gispert, J. D., Sánchez-Valle, R., Antonell, A., Rami, L., Molinuevo, J. L., Brosseron, F., Trachsel, A., Heneka, M. T., Struyfs, H., Engelborghs, S., … Haass, C. (2016). sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer’s disease and associate with neuronal injury markers. In <em>EMBO molecular medicine</em> (Vol. 8, Issue 5, pp.&nbsp;466–476). <em>EMBO molecular medicine</em>. <a href="https://doi.org/10.15252/emmm.201506123" class="uri">https://doi.org/10.15252/emmm.201506123</a></p></li>
<li><p>Wyss-Coray, T., &amp; Rogers, J. (n.d.). Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. <em>National Library of Medicine</em>. Retrieved December 14, 2024, from <a href="https://pubmed.ncbi.nlm.nih.gov/22315714" class="uri">https://pubmed.ncbi.nlm.nih.gov/22315714</a></p></li>
<li><p>Cryan, J. F., O’Riordan, K. J., Sandhu, K., Peterson, V., &amp; Dinan, T. G. (2020). The gut microbiome in neurological disorders. In <em>The Lancet. Neurology</em> (Vol. 19, Issue 2, pp.&nbsp;179–194). The Lancet. Neurology. <a href="https://doi.org/10.1016/S1474-4422(19)30356-4">https://doi.org/10.1016/S1474-4422(19)30356-4<br>
</a></p></li>
<li><p>Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., Hazrati, L., Collinge, J., Pocock, J., Lashley, T., Williams, J., Lambert, J.-C., Amouyel, P., Goate, A., Rademakers, R., … undefined Alzheimer Genetic Analysis Group. (2013). TREM2 variants in Alzheimer’s disease. In <em>The New England journal of medicine</em> (Vol. 368, Issue 2, pp.&nbsp;117–127). The New England journal of medicine. <a href="https://doi.org/10.1056/NEJMoa1211851" class="uri">https://doi.org/10.1056/NEJMoa1211851</a></p></li>
</ul>



</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const onCopySuccess = function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  }
  const getTextToCopy = function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button:not([data-in-quarto-modal])', {
    text: getTextToCopy
  });
  clipboard.on('success', onCopySuccess);
  if (window.document.getElementById('quarto-embedded-source-code-modal')) {
    const clipboardModal = new window.ClipboardJS('.code-copy-button[data-in-quarto-modal]', {
      text: getTextToCopy,
      container: window.document.getElementById('quarto-embedded-source-code-modal')
    });
    clipboardModal.on('success', onCopySuccess);
  }
    var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
    var mailtoRegex = new RegExp(/^mailto:/);
      var filterRegex = new RegExp('/' + window.location.host + '/');
    var isInternal = (href) => {
        return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
    }
    // Inspect non-navigation links and adorn them if external
 	var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool):not(.about-link)');
    for (var i=0; i<links.length; i++) {
      const link = links[i];
      if (!isInternal(link.href)) {
        // undo the damage that might have been done by quarto-nav.js in the case of
        // links that we want to consider external
        if (link.dataset.originalHref !== undefined) {
          link.href = link.dataset.originalHref;
        }
      }
    }
  function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
    const config = {
      allowHTML: true,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start',
    };
    if (contentFn) {
      config.content = contentFn;
    }
    if (onTriggerFn) {
      config.onTrigger = onTriggerFn;
    }
    if (onUntriggerFn) {
      config.onUntrigger = onUntriggerFn;
    }
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      if (note) {
        return note.innerHTML;
      } else {
        return "";
      }
    });
  }
  const xrefs = window.document.querySelectorAll('a.quarto-xref');
  const processXRef = (id, note) => {
    // Strip column container classes
    const stripColumnClz = (el) => {
      el.classList.remove("page-full", "page-columns");
      if (el.children) {
        for (const child of el.children) {
          stripColumnClz(child);
        }
      }
    }
    stripColumnClz(note)
    if (id === null || id.startsWith('sec-')) {
      // Special case sections, only their first couple elements
      const container = document.createElement("div");
      if (note.children && note.children.length > 2) {
        container.appendChild(note.children[0].cloneNode(true));
        for (let i = 1; i < note.children.length; i++) {
          const child = note.children[i];
          if (child.tagName === "P" && child.innerText === "") {
            continue;
          } else {
            container.appendChild(child.cloneNode(true));
            break;
          }
        }
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(container);
        }
        return container.innerHTML
      } else {
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(note);
        }
        return note.innerHTML;
      }
    } else {
      // Remove any anchor links if they are present
      const anchorLink = note.querySelector('a.anchorjs-link');
      if (anchorLink) {
        anchorLink.remove();
      }
      if (window.Quarto?.typesetMath) {
        window.Quarto.typesetMath(note);
      }
      if (note.classList.contains("callout")) {
        return note.outerHTML;
      } else {
        return note.innerHTML;
      }
    }
  }
  for (var i=0; i<xrefs.length; i++) {
    const xref = xrefs[i];
    tippyHover(xref, undefined, function(instance) {
      instance.disable();
      let url = xref.getAttribute('href');
      let hash = undefined; 
      if (url.startsWith('#')) {
        hash = url;
      } else {
        try { hash = new URL(url).hash; } catch {}
      }
      if (hash) {
        const id = hash.replace(/^#\/?/, "");
        const note = window.document.getElementById(id);
        if (note !== null) {
          try {
            const html = processXRef(id, note.cloneNode(true));
            instance.setContent(html);
          } finally {
            instance.enable();
            instance.show();
          }
        } else {
          // See if we can fetch this
          fetch(url.split('#')[0])
          .then(res => res.text())
          .then(html => {
            const parser = new DOMParser();
            const htmlDoc = parser.parseFromString(html, "text/html");
            const note = htmlDoc.getElementById(id);
            if (note !== null) {
              const html = processXRef(id, note);
              instance.setContent(html);
            } 
          }).finally(() => {
            instance.enable();
            instance.show();
          });
        }
      } else {
        // See if we can fetch a full url (with no hash to target)
        // This is a special case and we should probably do some content thinning / targeting
        fetch(url)
        .then(res => res.text())
        .then(html => {
          const parser = new DOMParser();
          const htmlDoc = parser.parseFromString(html, "text/html");
          const note = htmlDoc.querySelector('main.content');
          if (note !== null) {
            // This should only happen for chapter cross references
            // (since there is no id in the URL)
            // remove the first header
            if (note.children.length > 0 && note.children[0].tagName === "HEADER") {
              note.children[0].remove();
            }
            const html = processXRef(null, note);
            instance.setContent(html);
          } 
        }).finally(() => {
          instance.enable();
          instance.show();
        });
      }
    }, function(instance) {
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            div.style.left = 0;
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
        // Handle positioning of the toggle
    window.addEventListener(
      "resize",
      throttle(() => {
        elRect = undefined;
        if (selectedAnnoteEl) {
          selectCodeLines(selectedAnnoteEl);
        }
      }, 10)
    );
    function throttle(fn, ms) {
    let throttle = false;
    let timer;
      return (...args) => {
        if(!throttle) { // first call gets through
            fn.apply(this, args);
            throttle = true;
        } else { // all the others get throttled
            if(timer) clearTimeout(timer); // cancel #2
            timer = setTimeout(() => {
              fn.apply(this, args);
              timer = throttle = false;
            }, ms);
        }
      };
    }
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
</div> <!-- /content -->




</body></html>